The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Defining normoxia, physoxia and hypoxia in tumours—implications for treatment response
Open accessAbstract
Tumour hypoxia is increasingly recognized as a major deleterious factor in cancer therapies, as it compromises treatment and drives malignant progression. This review seeks to clarify the oxygen levels that are pertinent to this issue. It is argued that normoxia (20% oxygen) is an extremely poor comparator for "physoxia", i.e. the much lower levels of oxygen universally found in normal tissues, which averages about 5% oxygen, and ranges from about 3% to 7.4%. Importantly, it should be recognized that the median oxygenation in untreated tumours is significantly much lower, falling between approximately 0.3% and 4.2% oxygen, with most tumours exhibiting median oxygen levels <2%. This is partially dependent on the tissue of origin, and it is notable that many prostate and pancreatic tumours are profoundly hypoxic. In addition, therapy can induce even further, often unrecognized, changes in tumour oxygenation that may vary longitudinally, increasing or decreasing during treatment in ways that are not always predictable. Studies that fail to take cognizance of the actual physiological levels of oxygen in tissues (approximately 5%) and tumours (approximately 1%) may fail to identify the real circumstances driving tumour response to treatment and/or malignant progression. This can be of particular importance in genetic studies in vitro when comparison to human tumours is required.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Reduced oxygen tension activates a conserved hypoxic signaling network centered on hypoxia-inducible factors (HIFs)”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [2]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Nevertheless, both physiological and pathological states can transiently disrupt the equilibrium between oxygen supply and demand, resulting in tissue and cellular hypoxia”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [2]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In liver metastases of colorectal cancer, the median PO2 was 6 mmHg as compared with 30 mmHg in normal liver tissue (20).”
From HIF inhibitor 32-134D eradicates murine hepatocellular carcinoma in combination with anti-PD1 therapy (2022) · cites this paper as [20]
The cited source says what the claim attributes to it.
In the citing paper
“This response features extensive transcriptional reprogramming aimed at preserving cellular integrity under low-oxygen conditions”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Lysyl oxidase is essential for hypoxia-induced metastasis
Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T. A., Jeffrey, S. S., & Giaccia, A. J. (2006) · Nature · doi:10.1038/nature04695 · Cited by 1,309
RetractedWarburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Molecular mechanisms and clinical applications of angiogenesis
Carmeliet, P., & Jain, R. K. (2011) · Nature · doi:10.1038/nature10144 · Cited by 5,467
Hypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177
Radiobiology for the Radiologist.
(1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-80-3-438_1 · Cited by 3,498
Targeting hypoxia in cancer therapy
Wilson, W. R., & Hay, M. P. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3064 · Cited by 3,172
Modes of resistance to anti-angiogenic therapy
Bergers, G., & Hanahan, D. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2442 · Cited by 2,953
Exploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828
Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects
Hockel, M., & Vaupel, P. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.4.266 · Cited by 2,662
Pàez‐Ribes, M., Allen, E., Hudock, J., Takeda, T., Okuyama, H., Viñals, F., Inoue, M., Bergers, G., Hanahan, D., & Casanovas, O. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.027 · Cited by 2,373
Research works printed but not linked: 8
- Vaupel P, 2010, Exp Oncol, 32, 125
- Vaupel P, 2003, Cancer Res, 63, 7634
- Höckel M, 1991, Cancer Res, 51, 6098
- Kallinowski F, 1995, Tumor oxygenation, 291
- Kallinowski F, 1995, Tumor oxygenation, 205
- Vaupel P, 2006, Eur J Gynaecol Oncol, 27, 142
- Stone JE, 2005, Eur J Gynaecol Oncol, 26, 31
- Cairns RA, 2001, Cancer Res, 61, 8903
Cited by
Sorted by citations
Items 401–500 of 1,000
Air‐Stable Silicon Nanocrystal‐Based Photon Upconversion
Xia, P., Schwan, J., Dugger, T. W., Mangolini, L., & Tang, M. L. (2021) · Advanced Optical Materials · doi:10.1002/adom.202100453 · Cited by 18
Köthe, A., Bizzocchi, N., Safai, S., Lomax, A., Weber, D. C., & Fattori, G. (2021) · Radiation Oncology · doi:10.1186/s13014-021-01914-2 · Cited by 18
Zhang, C., Wu, L., Li, Z.-D., Zhang, M., Wu, J., Du, F., Zeng, L., & Li, Y.-L. (2022) · International Journal of Oncology · doi:10.3892/ijo.2022.5335 · Cited by 18
Precise and fast control of the dissolved oxygen level for tumor-on-chip
Bouquerel, C., César, W., Barthod, L., Arrak, S., Battistella, A., Gropplero, G., Mechta‐Grigoriou, F., Zalcman, G., Parrini, M. C., Verhulsel, M., et al. (2022) · Lab on a Chip · doi:10.1039/d2lc00696k · Cited by 18
Inhibition of HIF1α and PDK Induces Cell Death of Glioblastoma Multiforme
Han, J. E., Lim, P. W., Na, C. M., Choi, Y. S., Lee, J. Y., Kim, Y., Park, H. W., Moon, H. E., Heo, M. S., Park, H. R., et al. (2017) · Experimental Neurobiology · doi:10.5607/en.2017.26.5.295 · Cited by 18
Herrera-Campos, A. B., Zamudio-Martinez, E., Delgado-Bellido, D., Fernández-Cortés, M., Montuenga, L. M., Oliver, F. J., & Garcia-Diaz, A. (2022) · Cancers · doi:10.3390/cancers14112740 · Cited by 17
Patel, S. V. (2017) · Gene · doi:10.1016/j.gene.2017.05.043 · Cited by 17
Camuri, İ. J., da Costa, A. B., Ito, A. S., & Pazin, W. M. (2018) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2018.02.059 · Cited by 17
Lu, X., Zhang, W., Zhang, J., Ren, D., Zhao, P., & Ying, Y. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18361 · Cited by 19
Flickinger, K. M., Wilson, K. M., Rossiter, N. J., Hunger, A. L., Vishwasrao, P., Lee, T. D., Fritz, C. M., Richards, R. M., Hall, M. D., & Cantor, J. R. (2024) · Science Advances · doi:10.1126/sciadv.adq3591 · Cited by 18
Ermi, A. G., & Sarkar, D. (2024) · Cancers · doi:10.3390/cancers16233944 · Cited by 21
Lindblom, E. K., Ureba, A., Daşu, A., Wersäll, P. J., Even, A. J. G., van Elmpt, W., Lambin, P., & Toma-Daşu, I. (2019) · Medical Physics · doi:10.1002/mp.13514 · Cited by 17
Gorodetskii, A. A., Eubank, T. D., Driesschaert, B., Poncelet, M., Ellis, E., Khramtsov, V. V., & Bobko, A. A. (2019) · Scientific Reports · doi:10.1038/s41598-019-48524-3 · Cited by 17
Kwon, Y., Lee, J. Y., La, M. T., Lee, S. J., Lee, S. H., Park, J. H., & Kim, H. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112099 · Cited by 17
Hijacking Sexual Immuno-Privilege in GBM—An Immuno-Evasion Strategy
Sharpe, M. A., Baskin, D. S., Jenson, A. V., & Baskin, A. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222010983 · Cited by 17
Reprogramming of glucocorticoid receptor function by hypoxia
Vanderhaeghen, T., Timmermans, S., Watts, D., Paakinaho, V., Eggermont, M., Vandewalle, J., Wallaeys, C., Wyngene, L. V., Looveren, K. V., Nuyttens, L., et al. (2021) · EMBO Reports · doi:10.15252/embr.202153083 · Cited by 17
Regulation of epithelial‐to‐mesenchymal transition in hypoxia by the HIF‐1α network
Wang, H., Zhang, X., & Wang, W. (2021) · FEBS Letters · doi:10.1002/1873-3468.14258 · Cited by 17
Peroxide mediated oxygen delivery in cancer therapy
Khorshidi, S., Younesi, S., & Karkhaneh, A. (2022) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2022.112832 · Cited by 19
Rieger, C. T., & Fiegl, M. (2016) · Experimental Hematology · doi:10.1016/j.exphem.2016.04.008 · Cited by 17
Functional Organotypic Cultures of Prostate Tissues
Figiel, S., Pasqualin, C., Bery, F., Maupoil, V., Vandier, C., Potier‐Cartereau, M., Domingo, I., Guibon, R., Bruyère, F., Mahéo, K., et al. (2019) · American Journal Of Pathology · doi:10.1016/j.ajpath.2019.02.017 · Cited by 17
The microenvironment of secondary lymphedema. The key to finding effective treatments?
Hossain, L., Gomes, K. P., Safarpour, S., & Gibson, S. B. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167677 · Cited by 17
AARS1 and AARS2: From Protein Synthesis to Lactylation-Driven Oncogenesis
Gao, L., Guo, J., & Jia, R. (2025) · Biomolecules · doi:10.3390/biom15091323 · Cited by 18
Role of oxygen sensing and hypoxia-inducible factors in orchestrating innate immune responses
Low, J. T., Kim, Y., Matsushita, M., & Ho, P. (2025) · Nature Immunology · doi:10.1038/s41590-025-02317-1 · Cited by 18
The role of tumor-derived exosomes in tumor angiogenesis and tumor progression
Głuszko, A., Mirza, S. M., Piszczatowska, K., Kantor, I., Struga, M., & Szczepański, M. J. (2019) · Current Issues in Pharmacy and Medical Sciences · doi:10.2478/cipms-2019-0034 · Cited by 16
The Promise of Targeting Hypoxia to Improve Cancer Immunotherapy: Mirage or Reality?
Janji, B., & Chouaı̈b, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.880810 · Cited by 18
Pachane, B. C., Nunes, A. C. C., Cataldi, T. R., Micocci, K. C., Moreira, B. C., Labate, C. A., Selistre-de-Araújo, H. S., & Altei, W. F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012646 · Cited by 15
Numprasit, W., Yangngam, S., Prasopsiri, J., Quinn, J. A., Edwards, J., & Thuwajit, C. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1087270 · Cited by 16
Chen, H.-Y., Lin, C., Wu, S.-C., Yang, Z., Chiang, Y., Huang, K., Wang, K.-L., Ali, M. K., Shieh, T., Chang, H., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115533 · Cited by 17
Role of Microenvironmental Components in Head and Neck Squamous Cell Carcinoma
Jumaniyazova, E. D., Lokhonina, А. V., Dzhalilova, D. S., Kosyreva, A. M., & Fatkhudinov, T. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13111616 · Cited by 19
ANGPTL4 regulates ovarian cancer progression by activating the ERK1/2 pathway
Xu, J., Wu, F., Zhu, Y., Wu, T., Cao, T., Gao, W., Liu, M., Qian, W., Feng, G., Xi, X., et al. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03246-z · Cited by 16
SerpinB3: A Multifaceted Player in Health and Disease—Review and Future Perspectives
Cagnin, S., Pontisso, P., & Martini, A. (2024) · Cancers · doi:10.3390/cancers16142579 · Cited by 16
Johnston, H., Dickinson, P., Ivens, A. C., Buck, A. H., Levine, R. D., Remacle, F., & Campbell, C. J. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1909455116 · Cited by 16
Young AIMN Working Group, Quartuccio, N., Laudicella, R., Mapelli, P., Guglielmo, P., Pizzuto, D. A., Boero, M., Arnone, G., & Picchio, M. (2020) · Clinical and Translational Imaging · doi:10.1007/s40336-020-00358-0 · Cited by 16
A Relatively Small Gradient of Extracellular pH Directs Migration of MDA-MB-231 Cells In Vitro
Takahashi, E., Yamaguchi, D., & Yamaoka, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072565 · Cited by 16
Eggert, S., Gutbrod, M. S., Liebsch, G., Meier, R., Meinert, C., & Hutmacher, D. W. (2021) · ACS Sensors · doi:10.1021/acssensors.0c02551 · Cited by 16
Exploiting metabolic vulnerabilities after anti-VEGF antibody therapy in ovarian cancer
Glassman, D., Kim, M. S., Spradlin, M., Badal, S., Taki, M., Bhattacharya, P., Dutta, P., Kingsley, C. V., Foster, K. I., Animasahun, O., et al. (2023) · iScience · doi:10.1016/j.isci.2023.106020 · Cited by 15
Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer
Bibby, B. A. S., Thiruthaneeswaran, N., Yang, L., Pereira, R. R., Moré, E., McArt, D. G., O’Reilly, P. G., Bristow, R. G., Williams, K. J., Choudhury, A., et al. (2021) · BMC Urology · doi:10.1186/s12894-021-00856-x · Cited by 15
Virus/Host Cell Crosstalk in Hypoxic HPV-Positive Cancer Cells
Hoppe‐Seyler, K., Mändl, J., Adrian, S., Kuhn, B. J., & Hoppe‐Seyler, F. (2017) · Viruses · doi:10.3390/v9070174 · Cited by 16
Luo, A., Gong, Y., Kim, H., & Chen, Y. (2020) · NAR Cancer · doi:10.1093/narcan/zcaa010 · Cited by 14
Gao, Y., Wu, D., Jia, D., Guo, Q., Wang, M., Yang, R., Zhang, X., Chen, M., & Zhang, D. (2021) · Stem Cells and Development · doi:10.1089/scd.2021.0084 · Cited by 15
Kinomics platform using GBM tissue identifies BTK as being associated with higher patient survival
Shboul, S. A., Curran, O. E., Alfaro, J. A., Lickiss, F., Nita, E., Kowalski, J., Naji, F., Nenutil, R., Ball, K. L., Krejčíř, R., et al. (2021) · Life Science Alliance · doi:10.26508/lsa.202101054 · Cited by 15
Chaudhary, P., Gwynne, D., Odlozilik, B., McMurray, A., Milluzzo, G., Maiorino, C., Doria, D., Ahmed, H., Romagnani, L., Alejo, A., et al. (2022) · Radiation Oncology · doi:10.1186/s13014-022-02024-3 · Cited by 15
Yuan, H., Chen, B., Chai, R., Gong, W., Wan, Z., Zheng, B., Hu, X., Guo, Y., Gao, S., Dai, Q., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.920131 · Cited by 15
The Role of Hypoxia-Inducible Factor 1α in the Regulation of Human Meibomian Gland Epithelial Cells
Liu, Y., Wang, J., Chen, D., Kam, W. R., & Sullivan, D. A. (2020) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.61.3.1 · Cited by 15
Dailey, K. M., Allgood, J. E., Johnson, P. R., Ostlie, M. A., Schaner, K., Brooks, B. D., & Brooks, A. E. (2021) · Future Microbiology · doi:10.2217/fmb-2020-0245 · Cited by 15
Huang, T. H., Huang, W. T., & Bian, Q. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114222 · Cited by 14
Dailey, K. M., Jacobson, R. I., Johnson, P. R., Woolery, T. J., Kim, J., Jansen, R. J., Mallik, S., & Brooks, A. E. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.624618 · Cited by 14
Cancer Metabolism and Ischemia-Reperfusion Injury: Two Sides of the Same Coin
Nemeth, D. V., Baldini, E., Sorrenti, S., D’Andrea, V., & Bellini, M. I. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11175096 · Cited by 15
LINC00839 promotes malignancy of liver cancer via binding FMNL2 under hypoxia
Xie, Y., Lin, H., Wei, W., Kong, Y., Fang, Q., Chen, E., Liu, J., & Li, M. (2022) · Scientific Reports · doi:10.1038/s41598-022-16972-z · Cited by 14
Dual-Targeting Biomimetic Nanomaterials for Photo-/Chemo-/Antiangiogenic Synergistic Therapy
Zhang, Y., Yang, N., Dong, Z., Wu, J., Liao, R. J., Zhang, Y., Zhang, G., Ren, M., Wang, F., Dong, X., et al. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c03471 · Cited by 14
Kishimoto, S., Devasahayam, N., Chandramouli, G. V. R., Murugesan, R., Otowa, Y., Yamashita, K., Yamamoto, K., Brender, J., & Krishna, M. C. (2023) · Magnetic Resonance in Medicine · doi:10.1002/mrm.29811 · Cited by 14
Hypoxia-induced activation of NDR2 underlies brain metastases from Non-Small Cell Lung Cancer
Levallet, J., Biojout, T., Bazille, C., Douyère, M., Dubois, F., Ferreira, D. L., Taylor, J., Teulier, S., Toutain, J., Elie, N., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06345-3 · Cited by 14
A Simple Framework for Agent-Based Modeling with Extracellular Matrix
Metzcar, J., Duggan, B. S., Fischer, B., Murphy, M., Heiland, R. W., & Macklin, P. (2025) · Bulletin of Mathematical Biology · doi:10.1007/s11538-024-01408-8 · Cited by 14
Attenuation of ATM signaling by ROS delays replicative senescence at physiological oxygen
Stuart, A., Takai, K., Gabbasova, R. R., Sanford, H., Vinogradova, E. V., & de Lange, T. (2025) · Molecular Cell · doi:10.1016/j.molcel.2025.11.006 · Cited by 13
miR‐210 is induced by hypoxia and regulates neural cell adhesion molecule in prostate cells
Angel, C. Z., Lynch, S. M., Nesbitt, H., McKenna, M. M., Walsh, C. P., & McKenna, D. J. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29548 · Cited by 14
Suicide gene strategies applied in ovarian cancer studies
Nguyen, Q. M., Dupré, P., Haute, T., Montier, T., & d’Arbonneau, F. (2023) · Cancer Gene Therapy · doi:10.1038/s41417-023-00590-6 · Cited by 20
Yu, L., Peng, Y., Jiang, L., & Qiu, L. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c07742 · Cited by 14
Can hi-jacking hypoxia inhibit extracellular vesicles in cancer?
Lowry, M. C., & O’Driscoll, L. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.03.006 · Cited by 15
The response of five intestinal cell lines to anoxic conditions in vitro
Vissenaekens, H., Grootaert, C., Rajković, A., de Wiele, T. V., & Calatayud, M. (2019) · Biology of the Cell · doi:10.1111/boc.201800076 · Cited by 14
Pseudohypoxic stabilization of HIF1α via cyclophilin D suppression promotes melanoma metastasis
Park, H., Hu, S., Kim, S. Y., Yoon, S., Yoon, N. G., Lee, J. H., Choi, W., Kong, S., Kim, J. H., Nam, D., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02314-8 · Cited by 16
Delprat, V., Huart, C., Féron, O., Soncin, F., & Michiels, C. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.961753 · Cited by 13
Advanced in vitro models for renal cell carcinoma therapy design
Mieville, V., Griffioen, A. W., Benamran, D. A., & Nowak-Sliwinska, P. M. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188942 · Cited by 12
Associations between HIFs and tumor immune checkpoints: mechanism and therapy
Liu, J., Jiang, Y., Chen, L., Qian, Z., & Zhang, Y. (2024) · Discover Oncology · doi:10.1007/s12672-023-00836-7 · Cited by 13
Hypoxia-Activated Theragnostic Prodrugs (HATPs): Current State and Future Perspectives
Bhuniya, S., & Vrettos, E. I. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16040557 · Cited by 13
Targeting ARNT attenuates chemoresistance through destabilizing p38α-MAPK signaling in glioblastoma
Wahafu, A., Lv, G., Zheng, J., Cai, H., Wu, W., Yang, Y., Du, S., Zhou, D., & Wang, P. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06735-1 · Cited by 13
Peng, C., Wang, Y., Guo, Y., Li, J., Liu, F., Fu, Y., Yu, Y., Chengxin, Z., Fu, J., & Han, F. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118491 · Cited by 14
de Bakker, T., Maes, A., Dragan, T., Martinive, P., Penninckx, S., & Gestel, D. V. (2024) · Cells · doi:10.3390/cells14010018 · Cited by 18
Masuda, T., Koto, M., Ikawa, H., Takei, H., Aoki, K., Nakaji, T., Kasamatsu, K., & Inaniwa, T. (2025) · Physics in Medicine and Biology · doi:10.1088/1361-6560/adc5d6 · Cited by 13
Bernhardt, S., Tönsing, C., Mitra, D., Erdem, N., Müller‐Decker, K., Korf, U., Kreutz, C., Timmer, J., & Wiemann, S. (2019) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00944 · Cited by 13
Saxena, S., Agrawal, I., Singh, P., & Jha, S. (2020) · Medical Devices & Sensors · doi:10.1002/mds3.10064 · Cited by 13
Chan, C.-C., Chen, G. T. Y., & Hsiao, Y.-Y. (2021) · Cancers · doi:10.3390/cancers13122997 · Cited by 13
Tattenberg, S., Marants, R., Niepel, K., Bortfeld, T. R., Sudhyadhom, A., Landry, G., Parodi, K., & Verburg, J. (2022) · Physics in Medicine and Biology · doi:10.1088/1361-6560/ac950f · Cited by 13
The ‘stealth-bomber’ paradigm for deciphering the tumour response to carbon-ion irradiation
Wozny, A., & Rodriguez‐Lafrasse, C. (2023) · British Journal of Cancer · doi:10.1038/s41416-022-02117-6 · Cited by 15
The Role of Biomimetic Hypoxia on Cancer Cell Behaviour in 3D Models: A Systematic Review
Liu, Y., Mohri, Z., Alsheikh, W., & Cheema, U. (2021) · Cancers · doi:10.3390/cancers13061334 · Cited by 14
Functional profiling of murine glioma models highlights targetable immune evasion phenotypes
Mikolajewicz, N., Tatari, N., Wei, J., Savage, N. J., Farias, A. G., Dimitrov, V., Chen, D. Y., Zador, Z. E., Dasgupta, K., Aguilera-Uribe, M., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02831-w · Cited by 14
Modelling cancer metabolism in vitro: current improvements and future challenges
Dragic, H., Chaveroux, C., Cosset, E. C., & Manié, S. N. (2022) · FEBS Journal · doi:10.1111/febs.16704 · Cited by 14
The Importance of Hypoxia-Related to Hemoglobin Concentration in Breast Cancer
Chen, X., Zhou, H., & Lv, J. (2024) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-024-01386-7 · Cited by 12
Nrf2/ASPM axis regulated vasculogenic mimicry formation in hepatocellular carcinoma under hypoxia
Zhang, Y., Che, N., Wang, S., Meng, J., Zhao, N., Han, J., Dong, X., Li, Y., Mo, J., Zhao, X., et al. (2024) · Journal of Gastroenterology · doi:10.1007/s00535-024-02140-9 · Cited by 13
Schluter, H. M., Bariami, H., & Park, H. L. (2024) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph21081087 · Cited by 15
Gas Tunnel Engineering of Prolyl Hydroxylase Reprograms Hypoxia Signaling in Cells
Windsor, P. K., Ouyang, H., da Costa, J. A. G., Damodaran, A. R., Chen, Y., & Bhagi‐Damodaran, A. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202409234 · Cited by 13
Branco, H., Xavier, C. P. R., Riganti, C., & Vasconcelos, M. H. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189244 · Cited by 13
HIF-1α, NOTCH1, ADAM12, and HB-EGF are overexpressed in mucoepidermoid carcinoma
Branco, D. C., da Costa, N. M. M., Abe, C. T. S., Kataoka, M. S. D. S., Pinheiro, J. D. J. V., & Júnior, S. D. M. A. (2018) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2018.09.013 · Cited by 12
Chen, A. M., Lashmet, M., Isidan, A., Sterner, J., Walsh, J., Koehler, C., Li, P., Ekser, B., & Smith, L. J. (2020) · Scientific Reports · doi:10.1038/s41598-020-64256-1 · Cited by 12
Modulation of cell physiology under hypoxia in pancreatic cancer
Estarás, M., & González, A. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i28.4582 · Cited by 12
Steinberger, K. J., & Eubank, T. D. (2023) · Oxygen · doi:10.3390/oxygen3010005 · Cited by 15
khooy, M. J. M., Farasat, M., Salmi, M. S., & Mirzaei, H. (2023) · Phytotherapy Research · doi:10.1002/ptr.7716 · Cited by 12
Chowkwale, M., Mahler, G. J., Huang, P., & Murray, B. T. (2019) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2019.08.012 · Cited by 12
Eriksson, J. A., Wanka, C., Burger, M. C., Urban, H., Hartel, I. A., von Renesse, J., Harter, P. N., Mittelbronn, M. G. A., Steinbach, J., & Rieger, J. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14264 · Cited by 12
Aurora B Kinase Promotes CHIP-Dependent Degradation of HIF1α in Prostate Cancer Cells
Biswas, K., Sarkar, S., Said, N. A., Brautigan, D. L., & Larner, J. M. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-19-0777 · Cited by 13
Li, Z., Teng, M., Wang, Y., Feng, Y., Xiao, Z., Hu, H., Wang, Q., Lu, Y., Li, C., Zeng, K., et al. (2020) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2020.102078 · Cited by 12
Barmaki, S., Obermaier, D., Kankuri, E. M., Vuola, J., Franssila, S., & Jokinen, V. P. (2020) · Micromachines · doi:10.3390/mi11110979 · Cited by 12
A guide to reactive oxygen species in tumour hypoxia: measurement and therapeutic implications
Hacker, L., Sarsam, E., Conway, S. J., & Hammond, E. M. (2025) · Molecular Oncology · doi:10.1002/1878-0261.70151 · Cited by 13
Metabolism in the tumor microenvironment: implications for pathogenesis and therapeutics
Wik, J. A., Berge, E. R., Stromsnes, K., & Skålhegg, B. S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1610255 · Cited by 13
The role of ionizing radiation-initiated reactions in targeted activation of chemotherapeutics
Liu, J., Denkova, A. G., & Eelkema, R. (2025) · Nature Reviews Chemistry · doi:10.1038/s41570-025-00779-3 · Cited by 12
Tian, L., Jia, Z., Yan, Y., Jia, Q., Shi, W., Cui, S., Chen, H., Han, Y., Zhao, X., & He, K. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1155414 · Cited by 11
Lu, Y., Zhou, Q.-M., Yang, X., Zhou, J.-P., Wang, X.-J., Yu, J., Zhang, J.-G., Du, Y., & Yu, R. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.148610 · Cited by 11
Zhang, H., Li, X., Liu, Z., Lin, Z., Huang, K., Wang, Y., Chen, Y., Liao, L., Wu, L., Xie, Z., et al. (2024) · Cancer & Metabolism · doi:10.1186/s40170-024-00334-6 · Cited by 11
Kothari, R., & Venuganti, V. V. K. (2024) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2024.113002 · Cited by 11
Atta, D., Abou‐Shanab, A. M., Kamar, S. S., Soliman, M. W., Magdy, S., & El‐Badri, N. (2025) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.37882 · Cited by 11
STAMATAKOS, G. S., Kolokotroni, E. A., Panagiotidou, F., Tsampa, S., Kyroudis, C. A., Spohn, S. K. B., Grosu, A., Baltas, D., Zamboglou, C., & Sachpazidis, I. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1434739 · Cited by 11
Metadata
- Authors
- McKeown, S. R.
- Affiliations
- University of Ulster (GB)
- Corresponding author
- McKeown, S R
- Venue
- The British Journal of Radiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-03
- Volume
- 87
- Issue
- 1035
- Pages
- 20130676
- ISSN
- 0007-1285 (ISSN-L)
- 1748-880X
- PMC
- PMC4064601
- OpenAlex
- W2018722597
- Cited by
- 1,050
- References
- 126
- Citations by year
- 2026: 84 · 2025: 122 · 2024: 129 · 2023: 139 · 2022: 137 · 2021: 152 · 2020: 107 · 2019: 68 · 2018: 56 · 2017: 33 · 2016: 13 · 2015: 5 · 2014: 4
- FWCI
- 1.82
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- British Journal of Radiology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- tumor hypoxia, tumor oxygenation, normoxia, treatment response, prostate cancer, pancreatic cancer, malignant progression
- MeSH terms
- Animals, Hypoxia, Humans, Male, Neoplasms, Oxygen, Cell Hypoxia, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
